跳至主要内容
临床试验/NCT03961113
NCT03961113终止不适用

Pilot Study of the Impact of Giant Cell Arteritis and Its Treatment on the Autonomy of the Elderly in the First Year of Care

University Hospital, Limoges1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2019年5月17日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
10
试验地点
1
主要终点
Activities of Daily Living (ADL)

研究概览

简要总结

Giant cell arteritis is the leading cause of vasculitis in the elderly. No work evaluates its impact on autonomy. At the diagnosis a gerontological evaluation will be carried out including the scores ADL, iADL, MNA, SF 36, SPPB, FRIED and GDS. A monthly telephone reassessment will collect ADL and iADL. The end-of-study consultation at M12, conducted by a geriatrician, will have the same scores as at M0. This will make it possible to evaluate the difference in the functional autonomy score between M0 and M12 in the elderly with ACG.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age greater than or equal to 65 years with at least 2 comorbidities * present, or age greater than or equal to 75 years
  • Diagnosis of ACG meeting the diagnostic criteria of ACG 1990 ACR
  • comorbidity = chronic pathology

排除标准

  • Neoplastic pathology under treatment
  • Brain pathology with motor disability
  • Dementia at a severe stage (MMS <22/30)
  • Unable to answer the phone
  • Participation in a therapeutic clinical trial

结局指标

主要结局

Activities of Daily Living (ADL)

时间窗: Month 12

Compare score between Month 0 and Month 12. The scale is evaluated from 0 (dependence) to 6 (autonomy).

次要结局

  • Activities of Daily Living (ADL)(Month 11)

研究者

发起方
University Hospital, Limoges
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Pilot Study of the Impact of Giant Cell Arteritis... | 临床试验